Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab

Molecular Pharmaceutics

Volumn 10, Issue 12, 2013, Pages 4676-4686

  Yandrapu, Sarath K ^a   Upadhyay, Arun K ^a   Petrash, J Mark ^a   Kompella, Uday B ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b The University of Colorado Denver   (United States)

Author keywords

bevacizumab; intravitreal; noninvasive fluorophotometry; PLGA; supercritical fluid; sustained release

Indexed keywords

BEVACIZUMAB; POLYGLACTIN; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; FLUOROPHOTOMETRY; GEL PERMEATION CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POROSITY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SUPERCRITICAL INFUSION AND PRESSURE QUENCH TECHNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CARBON DIOXIDE; EYE; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POROSITY; PRESSURE; RATS; SOLVENTS;

EID: 84889255994     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400487f     Document Type: Article

References (29)

1. Wong, T. Y.; Chakravarthy, U.; Klein, R.; Mitchell, P.; Zlateva, G.; Buggage, R.; Fahrbach, K.; Probst, C.; Sledge, I. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration: A Systematic Review of the Literature and Meta-Analysis Ophthalmology 2008, 115 (1) 116-26
2. Fine, S. L.; Berger, J. W.; Maguire, M. G.; Ho, A. C. Age-Related Macular Degeneration N. Engl. J. Med. 2000, 342 (7) 483-92 (Pubitemid 30100237)
3. Narayanan, R.; Kuppermann, B. D.; Jones, C.; Kirkpatrick, P. Ranibizumab Nat. Rev. Drug Discovery 2006, 5 (10) 815-6 (Pubitemid 44480535)
4. Fine, S. L.; Martin, D. F.; Kirkpatrick, P. Pegaptanib Sodium Nat. Rev. Drug Discovery 2005, 4 (3) 187-8 (Pubitemid 40372548)
5. Stewart, M. W.; Grippon, S.; Kirkpatrick, P. Aflibercept Nat. Rev. Drug Discovery 2012, 11 (4) 269-70
6. Bashshur, Z. F.; Haddad, Z. A.; Schakal, A.; Jaafar, R. F.; Saab, M.; Noureddin, B. N. Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: A One-Year Prospective Study Am. J. Ophthalmol. 2008, 145 (2) 249-256
7. Avery, R. L. Regression of Retinal and Iris Neovascularization after Intravitreal Bevacizumab (Avastin) Treatment Retina 2006, 26 (3) 352-4 (Pubitemid 44318195)
8. Arevalo, J. F.; Fromow-Guerra, J.; Sanchez, J. G.; Maia, M.; Berrocal, M. H.; Wu, L.; Saravia, M. J.; Costa, R. A. Primary Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of the Pan-American Collaborative Retina Study Group at 12 Months Follow-Up Retina 2008, 28 (10) 1387-94
9. Schmucker, C.; Ehlken, C.; Hansen, L. L.; Antes, G.; Agostini, H. T.; Lelgemann, M. Intravitreal Bevacizumab (Avastin) Vs. Ranibizumab (Lucentis) for the Treatment of Age-Related Macular Degeneration: A Systematic Review Curr. Opin. Ophthalmol. 2010, 21 (3) 218-26
10. Jonas, J. B.; Spandau, U. H.; Schlichtenbrede, F. Short-Term Complications of Intravitreal Injections of Triamcinolone and Bevacizumab Eye (London) 2008, 22 (4) 590-1 (Pubitemid 351560425)
11. Geroski, D. H.; Edelhauser, H. F. Drug Delivery for Posterior Segment Eye Disease Invest. Ophthalmol. Visual Sci. 2000, 41 (5) 961-4 (Pubitemid 30187528)
12. Lam, X. M.; Duenas, E. T.; Daugherty, A. L.; Levin, N.; Cleland, J. L. Sustained Release of Recombinant Human Insulin-Like Growth Factor-I for Treatment of Diabetes J. Controlled Release 2000, 67 (2-3) 281-92 (Pubitemid 30303842)
13. Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres Pharm. Res. 1991, 8 (6) 713-20
14. Jain, R. A. The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (Plga) Devices Biomaterials 2000, 21 (23) 2475-90
15. Takada, S.; Yamagata, Y.; Misaki, M.; Taira, K.; Kurokawa, T. Sustained Release of Human Growth Hormone from Microcapsules Prepared by a Solvent Evaporation Technique J. Controlled Release 2003, 88 (2) 229-42 (Pubitemid 36287340)
16. Berkland, C.; Kim, K.; Pack, D. W. Fabrication of Plg Microspheres with Precisely Controlled and Monodisperse Size Distributions J. Controlled Release 2001, 73 (1) 59-74 (Pubitemid 32406102)
17. Ye, M.; Kim, S.; Park, K. Issues in Long-Term Protein Delivery Using Biodegradable Microparticles J. Controlled Release 2010, 146 (2) 241-60
18. Short, B. G. Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations Toxicol. Pathol. 2008, 36 (1) 49-62
19. Jiskoot, W.; Randolph, T. W.; Volkin, D. B.; Middaugh, C. R.; Schoneich, C.; Winter, G.; Friess, W.; Crommelin, D. J.; Carpenter, J. F. Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release J. Pharm. Sci. 2012, 101 (3) 946-54
20. Schwendeman, S. P. Recent Advances in the Stabilization of Proteins Encapsulated in Injectable Plga Delivery Systems Crit. Rev. Ther. Drug Carrier Syst. 2002, 19 (1) 73-98 (Pubitemid 34521249)
21. van de Weert, M.; Hennink, W. E.; Jiskoot, W. Protein Instability in Poly(Lactic-Co-Glycolic Acid) Microparticles Pharm. Res. 2000, 17 (10) 1159-67
22. Moshashaee, S.; Bisrat, M.; Forbes, R. T.; Nyqvist, H.; York, P. Supercritical Fluid Processing of Proteins. I: Lysozyme Precipitation from Organic Solution Eur. J. Pharm. Sci. 2000, 11 (3) 239-45 (Pubitemid 30616447)
23. Kompella, U. B.; Koushik, K. Preparation of Drug Delivery Systems Using Supercritical Fluid Technology Crit. Rev. Ther. Drug Carrier Syst. 2001, 18 (2) 173-99 (Pubitemid 32378147)
24. Mayo, A. S.; Ambati, B. K.; Kompella, U. B. Gene Delivery Nanoparticles Fabricated by Supercritical Fluid Extraction of Emulsions Int. J. Pharm. 2010, 387 (1-2) 278-85
25. Koushik, K.; Kompella, U. B. Preparation of Large Porous Deslorelin-PLGA Microparticles with Reduced Residual Solvent and Cellular Uptake Using a Supercritical Carbon Dioxide Process Pharm. Res. 2004, 21 (3) 524-35 (Pubitemid 38338989)
26. Tyagi, P.; Kadam, R. S.; Kompella, U. B. Comparison of Suprachoroidal Drug Delivery with Subconjunctival and Intravitreal Routes Using Noninvasive Fluorophotometry PLoS One 2012, 7 (10) e48188
27. Crotts, G.; Park, T. G. Protein Delivery from Poly(Lactic-Co-Glycolic Acid) Biodegradable Microspheres: Release Kinetics and Stability Issues J. Microencapsulation 1998, 15 (6) 699-713 (Pubitemid 28490941)
28. Houchin, M. L.; Topp, E. M. Chemical Degradation of Peptides and Proteins in Plga: A Review of Reactions and Mechanisms J. Pharm. Sci. 2008, 97 (7) 2395-404
29. Shive, M. S.; Anderson, J. M. Biodegradation and Biocompatibility of PLA and PLGA Microspheres Adv. Drug Delivery Rev. 1997, 28 (1) 5-24 (Pubitemid 27497671)